| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.41 | 4e-08 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.24 | 0.0005 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.2 | 0.002 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.22 | 0.003 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.17 | 0.01 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.15 | 0.02 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.11 | 0.09 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.11 | 0.1 |